A study to identify and evaluate the adverse drug reactions among patients on anti-tubercular medications
Not Applicable
- Conditions
- Health Condition 1: A15-A19- Tuberculosis
- Registration Number
- CTRI/2020/12/029554
- Lead Sponsor
- TEP RNTCP OR three Programme Government of Karnataka
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All adults with drug sensitive tuberculosis who are on anti-tubercular treatment for 6 months will be included in the study. The total study duration is for 12 months. All eligible TB patients from the four selected TUs will be enrolled in the study.
Exclusion Criteria
TB patients notified by private and transferred out to other than TUs selected for the study will be excluded
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The study will help us to understand the adverse drug reactions most commonly seen in patients with anti-tubercular medications under the National strategic plan of National tuberculosis elimination programme. <br/ ><br>Timepoint: 12 months <br/ ><br>
- Secondary Outcome Measures
Name Time Method To study the impact of adverse drug reactions on treatment outcome in tuberculosis.Timepoint: 12 months